Massive Bio

company

About

Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.

Details

Last Funding Type
Series B
Last Funding Money Raised
$16.50M
Industries
Artificial Intelligence,Big Data,Biotechnology,Clinical Trials,Genetics,Machine Learning,Medical,Pharmaceutical
Founded date
May 4, 2015
Number Of Employee
11 - 50
Operating Status
Active

Massive Bio, is an Artificial Intelligence (AI) powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development. Massive Bio combines technology, services and oncology sub-specialist expertise to maximize trial enrollment. Massive Bio is the first company that attacks controlling patient enrollment value chain; Massive Bio does patient identification through direct direct and indirect patient acquisition channels, pre-screening through virtual site, Just-In-Time (JIT) site activation and further analyzes real world data for drug discovery. One of the major differentiating point of Massive Bio is that the Company tackles “last mile” issues for trial enrollment to eliminate site and/or financial considerations of patients. Massive Bio is the go to partner for pharmaceutical companies and CROs to get the right patient at the right time.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$23.31M
Massive Bio has raised a total of $23.31M in funding over 2 rounds. Their latest funding was raised on Jun 2, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 2, 2022 Series B $16.50M 7 Kenan Turnacioglu
Revo Capital
Detail
Nov 3, 2020 Seed $2.81M 3 Revo Capital Detail
May 2, 2019 Seed $2M 2 International Private Bank (IPB) Detail
Jul 16, 2018 Seed $1.10M 1 UL Ventures Detail
Jul 4, 2016 Seed $0.90M 1 Detail

Investments

Number of Investments
Number of Lead Investments
4
1
Massive Bio has made 4 investments. Their most recent investment was on Dec 6, 2022, when GameOn Technology raised $35M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $35M Digital Media
Series B $35M Digital Media
Oct 19, 2021 Cardisio
Seed €3.50M Artificial Intelligence
Oct 30, 2012 ItsOn
Series B $15.50M Mobile Devices Yes

Employee Profiles

Number of Employee Profiles
5
Massive Bio has 5 current employee profiles, including Board member Kenan Turnacioglu
Board member
Executive
Executive
Executive